{"transactions":[{"id":746303,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T20:27:32.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":false,"shares":16988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":48012,"derivative":{"exercise_price":19.19,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":16988},"source":{"system":"sec-edgar","filing":"0001650131-26-000011","document":"form4-06082026_080628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000011/form4-06082026_080628.xml","form_type":"4"}},{"id":746302,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-06-08T20:27:32.000Z","date":"2026-06-05","kind":"exercise","planned":false,"acquired":true,"shares":16988,"price":19.19,"value":325999.72,"ownership":{"direct":true},"balance_after":57260,"source":{"system":"sec-edgar","filing":"0001650131-26-000011","document":"form4-06082026_080628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000011/form4-06082026_080628.xml","form_type":"4"}},{"id":838095,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Performance Restricted Stock Units","published_at":"2026-03-17T23:30:16.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares vest as follows:  2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001650131-26-000010","document":"form4-03172026_070307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000010/form4-03172026_070307.xml","form_type":"4"}},{"id":838094,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Performance Restricted Stock Units","published_at":"2026-03-17T23:30:16.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":7220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7220},"source":{"system":"sec-edgar","filing":"0001650131-26-000010","document":"form4-03172026_070307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000010/form4-03172026_070307.xml","form_type":"4"}},{"id":838093,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:16.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":16515,"price":91.9779,"value":1519015.0185,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units."}],"balance_after":40272,"source":{"system":"sec-edgar","filing":"0001650131-26-000010","document":"form4-03172026_070307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000010/form4-03172026_070307.xml","form_type":"4"}},{"id":838092,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:16.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":23000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":56787,"source":{"system":"sec-edgar","filing":"0001650131-26-000010","document":"form4-03172026_070307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000010/form4-03172026_070307.xml","form_type":"4"}},{"id":838091,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-17T23:30:16.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":7220,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":33787,"source":{"system":"sec-edgar","filing":"0001650131-26-000010","document":"form4-03172026_070307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000010/form4-03172026_070307.xml","form_type":"4"}},{"id":848740,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-11T20:05:19.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":false,"shares":5912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":54088,"derivative":{"exercise_price":15.87,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":5912},"source":{"system":"sec-edgar","filing":"0001650131-26-000008","document":"form4-03112026_080315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000008/form4-03112026_080315.xml","form_type":"4"}},{"id":848739,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-03-11T20:05:19.000Z","date":"2026-03-06","kind":"exercise","planned":false,"acquired":true,"shares":5912,"price":15.87,"value":93823.44,"ownership":{"direct":true},"balance_after":26567,"source":{"system":"sec-edgar","filing":"0001650131-26-000008","document":"form4-03112026_080315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000008/form4-03112026_080315.xml","form_type":"4"}},{"id":921998,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-02-04T02:45:09.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":2631,"price":103.3035,"value":271791.5085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":20655,"source":{"system":"sec-edgar","filing":"0001650131-26-000007","document":"form4-02032026_090206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000007/form4-02032026_090206.xml","form_type":"4"}},{"id":927024,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Performance Restricted Stock Units","published_at":"2026-01-30T23:30:06.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 23, 2024, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027."}],"balance_after":34500,"derivative":{"underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001650131-26-000005","document":"form4-01302026_060103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000005/form4-01302026_060103.xml","form_type":"4"}},{"id":927023,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-01-30T23:30:06.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":16280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":16280,"derivative":{"underlying":"Common Stock","underlying_shares":16280},"source":{"system":"sec-edgar","filing":"0001650131-26-000005","document":"form4-01302026_060103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000005/form4-01302026_060103.xml","form_type":"4"}},{"id":927022,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-30T23:30:06.000Z","date":"2026-01-28","kind":"grant","planned":false,"acquired":true,"shares":25120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 28, 2026 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":25120,"derivative":{"exercise_price":100.85,"expiration_date":"2036-01-27","underlying":"Common Stock","underlying_shares":25120},"source":{"system":"sec-edgar","filing":"0001650131-26-000005","document":"form4-01302026_060103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000005/form4-01302026_060103.xml","form_type":"4"}},{"id":930090,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-01-27T21:30:13.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":5750,"derivative":{"underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001650131-26-000003","document":"form4-01272026_040106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000003/form4-01272026_040106.xml","form_type":"4"}},{"id":930089,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-27T21:30:13.000Z","date":"2026-01-26","kind":"sale","planned":false,"acquired":false,"shares":3143,"price":96.192,"value":302331.456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":23286,"source":{"system":"sec-edgar","filing":"0001650131-26-000003","document":"form4-01272026_040106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000003/form4-01272026_040106.xml","form_type":"4"}},{"id":930088,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-27T21:30:13.000Z","date":"2026-01-23","kind":"exercise","planned":false,"acquired":true,"shares":5750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":26429,"source":{"system":"sec-edgar","filing":"0001650131-26-000003","document":"form4-01272026_040106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000003/form4-01272026_040106.xml","form_type":"4"}},{"id":932392,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2026-01-23T22:30:08.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":false,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":8333,"derivative":{"underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001650131-26-000002","document":"form4-01232026_050104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000002/form4-01232026_050104.xml","form_type":"4"}},{"id":932391,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:08.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":2382,"price":93.3252,"value":222300.6264,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":20679,"source":{"system":"sec-edgar","filing":"0001650131-26-000002","document":"form4-01232026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000002/form4-01232026_050104.xml","form_type":"4"}},{"id":932390,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2026-01-23T22:30:08.000Z","date":"2026-01-21","kind":"exercise","planned":false,"acquired":true,"shares":4167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 222 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":23061,"source":{"system":"sec-edgar","filing":"0001650131-26-000002","document":"form4-01232026_050104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000165013126000002/form4-01232026_050104.xml","form_type":"4"}},{"id":1200021,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Performance Restricted Stock Units","published_at":"2025-03-19T01:30:07.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":false,"shares":14440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."}],"balance_after":7220,"derivative":{"underlying":"Common Stock","underlying_shares":14440},"source":{"system":"sec-edgar","filing":"0001415889-25-008557","document":"form4-03182025_090304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925008557/form4-03182025_090304.xml","form_type":"4"}},{"id":1200020,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-19T01:30:07.000Z","date":"2025-03-17","kind":"sale","planned":false,"acquired":false,"shares":7879,"price":44.2143,"value":348364.4697,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units."}],"balance_after":18672,"source":{"system":"sec-edgar","filing":"0001415889-25-008557","document":"form4-03182025_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925008557/form4-03182025_090304.xml","form_type":"4"}},{"id":1200019,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-19T01:30:07.000Z","date":"2025-03-15","kind":"exercise","planned":false,"acquired":true,"shares":14440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":26551,"source":{"system":"sec-edgar","filing":"0001415889-25-008557","document":"form4-03182025_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925008557/form4-03182025_090304.xml","form_type":"4"}},{"id":1222692,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-05T21:28:19.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":1169,"price":45.74,"value":53470.06,"ownership":{"direct":true},"balance_after":12111,"source":{"system":"sec-edgar","filing":"0001415889-25-006955","document":"form4-03052025_090314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925006955/form4-03052025_090314.xml","form_type":"4"}},{"id":1222691,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-03-05T21:28:19.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":13681,"price":45.5711,"value":623458.2191,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":13280,"source":{"system":"sec-edgar","filing":"0001415889-25-006955","document":"form4-03052025_090314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925006955/form4-03052025_090314.xml","form_type":"4"}},{"id":1284970,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-02-04T22:30:14.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":2627,"price":48.2226,"value":126680.7702,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":26961,"source":{"system":"sec-edgar","filing":"0001415889-25-002982","document":"form4-02042025_050206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002982/form4-02042025_050206.xml","form_type":"4"}},{"id":1294540,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2025-01-27T21:50:37.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001415889-25-002137","document":"form4-01272025_090133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002137/form4-01272025_090133.xml","form_type":"4"}},{"id":1294539,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-01-27T21:50:37.000Z","date":"2025-01-24","kind":"sale","planned":false,"acquired":false,"shares":3177,"price":47.9245,"value":152256.1365,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":29588,"source":{"system":"sec-edgar","filing":"0001415889-25-002137","document":"form4-01272025_090133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002137/form4-01272025_090133.xml","form_type":"4"}},{"id":1294538,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-01-27T21:50:37.000Z","date":"2025-01-23","kind":"exercise","planned":false,"acquired":true,"shares":5750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer)."}],"balance_after":32765,"source":{"system":"sec-edgar","filing":"0001415889-25-002137","document":"form4-01272025_090133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925002137/form4-01272025_090133.xml","form_type":"4"}},{"id":1296437,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Performance Restricted Stock Units","published_at":"2025-01-23T22:51:44.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":21660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 31, 2023, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 31, 2023, the reporting person was granted performance restricted stock units (\"PSUs\") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026."}],"balance_after":21660,"derivative":{"underlying":"Common Stock","underlying_shares":21660},"source":{"system":"sec-edgar","filing":"0001415889-25-001952","document":"form4-01232025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001952/form4-01232025_100138.xml","form_type":"4"}},{"id":1296436,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2025-01-23T22:51:44.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-25-001952","document":"form4-01232025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001952/form4-01232025_100138.xml","form_type":"4"}},{"id":1296435,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T22:51:44.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 21, 2025 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":50000,"derivative":{"exercise_price":47.98,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-001952","document":"form4-01232025_100138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001952/form4-01232025_100138.xml","form_type":"4"}},{"id":1306736,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2025-01-08T21:44:22.000Z","date":"2025-01-07","kind":"sale","planned":false,"acquired":false,"shares":1998,"price":42.8153,"value":85544.9694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":27015,"source":{"system":"sec-edgar","filing":"0001415889-25-001144","document":"form4-01082025_090118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588925001144/form4-01082025_090118.xml","form_type":"4"}},{"id":1561933,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-25T21:41:42.000Z","date":"2024-03-25","kind":"sale","planned":false,"acquired":false,"shares":4303,"price":25.8,"value":111017.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $25.80, and the range of prices were between $25.80 and $25.825. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":29013,"source":{"system":"sec-edgar","filing":"0001415889-24-009046","document":"form4-03252024_090335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924009046/form4-03252024_090335.xml","form_type":"4"}},{"id":1572492,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-03-18T21:46:10.000Z","date":"2023-01-09","kind":"sale","planned":false,"acquired":false,"shares":1379,"price":20.6223,"value":28438.1517,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units."}],"balance_after":33316,"source":{"system":"sec-edgar","filing":"0001415889-24-008322","document":"form4-03182024_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924008322/form4-03182024_090306.xml","form_type":"4"}},{"id":1659005,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Common Stock","published_at":"2024-02-06T02:05:28.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":1790,"price":26.1917,"value":46883.143,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":34695,"source":{"system":"sec-edgar","filing":"0001415889-24-002755","document":"form4-02062024_020222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924002755/form4-02062024_020222.xml","form_type":"4"}},{"id":1669631,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:49:02.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.44,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001999371-24-000974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000974/ownership.xml","form_type":"4"}},{"id":1669630,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:49:02.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.21,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001999371-24-000974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000974/ownership.xml","form_type":"4"}},{"id":1669629,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:49:02.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42596,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.13,"underlying":"Common Stock","underlying_shares":42596},"source":{"system":"sec-edgar","filing":"0001999371-24-000974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000974/ownership.xml","form_type":"4"}},{"id":1669628,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T16:49:02.000Z","date":"2024-01-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13890,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under the Issuer's Amended and Restated 2018 Stock Option/Stock Issuance Plan or the Issuer's 2021 Equity Incentive Plan, pursuant to any inducement award or otherwise that was outstanding immediately prior to the Effective Time was cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.95,"underlying":"Common Stock","underlying_shares":13890},"source":{"system":"sec-edgar","filing":"0001999371-24-000974","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000974/ownership.xml","form_type":"4"}},{"id":1669627,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-01-26T16:49:02.000Z","date":"2024-01-26","kind":"other","planned":false,"acquired":false,"shares":8796,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Merger Agreement entered into by and among the Issuer, Pathos AI, Inc. (\"Parent\") and WK Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), dated as of December 13, 2023 (the \"Merger Agreement\"), pursuant to which Merger Sub completed a tender offer for all of the shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer effective as of January 26, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement, at the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive (i) $1.16 in cash without interest, plus (ii) one contingent value right."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001999371-24-000974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000199937124000974/ownership.xml","form_type":"4"}},{"id":1670978,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Restricted Stock Units","published_at":"2024-01-26T00:10:17.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":17250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the \"Vesting Commencement Date\"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date."}],"balance_after":17250,"derivative":{"underlying":"Common Stock","underlying_shares":17250},"source":{"system":"sec-edgar","filing":"0001415889-24-001823","document":"form4-01252024_070101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001823/form4-01252024_070101.xml","form_type":"4"}},{"id":1670977,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND COO"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-26T00:10:17.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 23, 2024 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":70000,"derivative":{"exercise_price":26.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001415889-24-001823","document":"form4-01252024_070101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924001823/form4-01252024_070101.xml","form_type":"4"}},{"id":1682804,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-01-10T01:28:12.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":1408,"price":28.0345,"value":39472.576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":36485,"source":{"system":"sec-edgar","filing":"0001415889-24-000884","document":"form4-01102024_010106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000141588924000884/form4-01102024_010106.xml","form_type":"4"}},{"id":1740887,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-11-16T01:11:33.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":218,"price":22.287,"value":4858.566,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 218 shares by the Reporting Person on November 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":37893,"source":{"system":"sec-edgar","filing":"0001209191-23-055433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123055433/doc4.xml","form_type":"4"}},{"id":1809957,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T21:12:50.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 35,000 shares of the Issuer's common stock, which will vest in full on the date of the 2024 Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":35000,"derivative":{"exercise_price":1.21,"expiration_date":"2033-08-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-23-090703","document":"tm2323614-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000110465923090703/tm2323614-7_4seq1.xml","form_type":"4"}},{"id":1836456,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-07-05T23:47:10.000Z","date":"2023-07-03","kind":"sale","planned":false,"acquired":false,"shares":1425,"price":25.6466,"value":36546.405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":37675,"source":{"system":"sec-edgar","filing":"0001209191-23-041344","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123041344/doc4.xml","form_type":"4"}},{"id":1884751,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-05-19T20:05:59.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":968,"price":16.9235,"value":16381.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 968 shares by the Reporting Person on May 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":39100,"source":{"system":"sec-edgar","filing":"0001209191-23-030964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123030964/doc4.xml","form_type":"4"}},{"id":2036328,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-02T22:41:04.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":57750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 31, 2023 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":57750,"derivative":{"exercise_price":23.48,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":57750},"source":{"system":"sec-edgar","filing":"0001209191-23-006302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123006302/doc4.xml","form_type":"4"}},{"id":2036327,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-02-02T22:41:04.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":14440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":38132,"source":{"system":"sec-edgar","filing":"0001209191-23-006302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919123006302/doc4.xml","form_type":"4"}},{"id":2118085,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-11-15T02:41:31.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":292,"price":17.051,"value":4978.892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 292 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":23692,"source":{"system":"sec-edgar","filing":"0001209191-22-056888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122056888/doc4.xml","form_type":"4"}},{"id":2178318,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-19T17:35:34.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's common stock, which will vest in full on June 1, 2023, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":20000,"derivative":{"exercise_price":2.44,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-22-029314","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924322029314/doc4.xml","form_type":"4"}},{"id":2273575,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-05-13T01:24:39.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":1169,"price":13.566,"value":15858.654,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,169 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":23400,"source":{"system":"sec-edgar","filing":"0001209191-22-028728","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122028728/doc4.xml","form_type":"4"}},{"id":2440181,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-07T21:55:27.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares vest one year after January 6, 2022 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":60000,"derivative":{"exercise_price":15.87,"expiration_date":"2032-01-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-22-002431","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122002431/doc4.xml","form_type":"4"}},{"id":2440180,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-01-07T21:55:27.000Z","date":"2022-01-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan."}],"balance_after":22231,"source":{"system":"sec-edgar","filing":"0001209191-22-002431","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919122002431/doc4.xml","form_type":"4"}},{"id":2512927,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-11-15T21:21:12.000Z","date":"2021-11-10","kind":"grant","acquired":true,"shares":958,"price":13.515,"value":12947.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 958 shares by the Reporting Person on November 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":12231,"source":{"system":"sec-edgar","filing":"0001209191-21-064450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121064450/doc4.xml","form_type":"4"}},{"id":2554495,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-02T00:00:12.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":1364,"price":19.2555,"value":26264.502,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021."}],"balance_after":11273,"source":{"system":"sec-edgar","filing":"0001209191-21-058605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121058605/doc4.xml","form_type":"4"}},{"id":2554494,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-10-02T00:00:12.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021.  On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 4,062 shares on September 29, 2021 and 4,063 shares on June 30, 2023."}],"balance_after":12637,"source":{"system":"sec-edgar","filing":"0001209191-21-058605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121058605/doc4.xml","form_type":"4"}},{"id":2716727,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-05-12T21:45:03.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":1006,"price":14.62,"value":14707.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 1,006 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":4512,"source":{"system":"sec-edgar","filing":"0001209191-21-032160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121032160/doc4.xml","form_type":"4"}},{"id":2738580,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-27T17:07:50.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8796},"source":{"system":"sec-edgar","filing":"0000899243-21-017114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017114/doc4.xml","form_type":"4"}},{"id":2738579,"issuer":{"id":94695,"kind":"organization","name":"Rain Oncology Inc.","symbol":"RAIN"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T17:07:50.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":8796,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date."}],"balance_after":8796,"source":{"system":"sec-edgar","filing":"0000899243-21-017114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1724979/000089924321017114/doc4.xml","form_type":"4"}},{"id":2911080,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-11T22:36:38.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after January 7, 2021 (the \"Vesting Commencement Date\") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date."}],"balance_after":65000,"derivative":{"exercise_price":19.19,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-21-003030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919121003030/doc4.xml","form_type":"4"}},{"id":2984078,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-11-12T22:16:51.000Z","date":"2020-11-10","kind":"grant","acquired":true,"shares":861,"price":15.266,"value":13144.026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 is being filed voluntarily to report the acquisition of 861 shares by the Reporting Person on November 10, 2020 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":3506,"source":{"system":"sec-edgar","filing":"0001209191-20-058052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919120058052/doc4.xml","form_type":"4"}},{"id":3166561,"issuer":{"id":2416,"kind":"organization","name":"Mirum Pharmaceuticals, Inc.","symbol":"MIRM"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-04-30T23:38:16.000Z","date":"2020-04-28","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares vest one year after April 28, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of April 28, 2020."}],"balance_after":185000,"derivative":{"exercise_price":16.26,"expiration_date":"2030-04-27","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001209191-20-026418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1759425/000120919120026418/doc4.xml","form_type":"4"}},{"id":4051140,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-16T19:12:09.000Z","date":"2018-02-14","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On August 11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On February 14, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On August 11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On February 14, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":5600,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000899243-18-004445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318004445/doc4.xml","form_type":"4"}},{"id":4051139,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-16T19:12:09.000Z","date":"2018-02-14","kind":"tax_withholding","acquired":false,"shares":794,"price":62.3,"value":49466.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,600 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":8833,"source":{"system":"sec-edgar","filing":"0000899243-18-004445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318004445/doc4.xml","form_type":"4"}},{"id":4051138,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-16T19:12:09.000Z","date":"2018-02-14","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 661 shares acquired under the Issuer's Employee Stock Purchase Plan (\"ESPP\") on July 31, 2017 and 549 shares acquired under the ESPP on January 31, 2018, each in a transaction exempt under Rule 16b-3."}],"balance_after":9627,"source":{"system":"sec-edgar","filing":"0000899243-18-004445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318004445/doc4.xml","form_type":"4"}},{"id":4057048,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-14T19:38:46.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":661,"price":13.69,"value":9049.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3345,"source":{"system":"sec-edgar","filing":"0000899243-18-003992","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318003992/doc5.xml","form_type":"5"}},{"id":4078460,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":17000,"derivative":{"underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078459,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":26500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying the option vest in 16 equal quarterly installments over 4 years from February 1, 2018, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":26500,"derivative":{"exercise_price":59.6,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":26500},"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078458,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On January 17, 2017, the Reporting Person was granted 24,000 RSUs, which vest in equal semi-annual installments over 4 years from February 1, 2017, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On January 17, 2017, the Reporting Person was granted 24,000 RSUs, which vest in equal semi-annual installments over 4 years from February 1, 2017, subject to the Reporting Person's continued employment with the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":18000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078457,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-02-02T20:17:09.000Z","date":"2018-01-31","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 31, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 31, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078456,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":812,"price":57.3,"value":46527.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":6817,"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078455,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"tax_withholding","acquired":false,"shares":1038,"price":59.6,"value":61864.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,000 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":7629,"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078454,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:17:09.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":8667,"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078453,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:17:09.000Z","date":"2018-01-31","kind":"tax_withholding","acquired":false,"shares":554,"price":57.9,"value":32076.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,600 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":5667,"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4078452,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-02T20:17:09.000Z","date":"2018-01-31","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's Common Stock."}],"balance_after":6221,"source":{"system":"sec-edgar","filing":"0000899243-18-002765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002765/doc4.xml","form_type":"4"}},{"id":4087845,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-01-26T17:24:55.000Z","date":"2018-01-24","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 24, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 24, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":8800,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000899243-18-002114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002114/doc4.xml","form_type":"4"}},{"id":4087844,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-26T17:24:55.000Z","date":"2018-01-24","kind":"tax_withholding","acquired":false,"shares":560,"price":58.15,"value":32564.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,600 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":4621,"source":{"system":"sec-edgar","filing":"0000899243-18-002114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002114/doc4.xml","form_type":"4"}},{"id":4087843,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-26T17:24:55.000Z","date":"2018-01-24","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":5181,"source":{"system":"sec-edgar","filing":"0000899243-18-002114","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002114/doc4.xml","form_type":"4"}},{"id":4089445,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-25T20:09:24.000Z","date":"2018-01-23","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option vested and became exercisable on November 17, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.61,"expiration_date":"2025-01-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-18-002043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002043/doc4.xml","form_type":"4"}},{"id":4089444,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-25T20:09:24.000Z","date":"2018-01-23","kind":"sale","acquired":false,"shares":30000,"price":60,"value":1800000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":3581,"source":{"system":"sec-edgar","filing":"0000899243-18-002043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002043/doc4.xml","form_type":"4"}},{"id":4089443,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-25T20:09:24.000Z","date":"2018-01-23","kind":"exercise","acquired":true,"shares":30000,"price":1.61,"value":48300.0,"ownership":{"direct":true},"balance_after":33581,"source":{"system":"sec-edgar","filing":"0000899243-18-002043","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318002043/doc4.xml","form_type":"4"}},{"id":4095588,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2018-01-18T19:38:05.000Z","date":"2018-01-16","kind":"exercise","acquired":false,"shares":1600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 16, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August  11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 16, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":10400,"derivative":{"underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0000899243-18-001363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318001363/doc4.xml","form_type":"4"}},{"id":4095587,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-18T19:38:05.000Z","date":"2018-01-16","kind":"tax_withholding","acquired":false,"shares":703,"price":52.1,"value":36626.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,600 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":3581,"source":{"system":"sec-edgar","filing":"0000899243-18-001363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318001363/doc4.xml","form_type":"4"}},{"id":4095586,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-18T19:38:05.000Z","date":"2018-01-16","kind":"exercise","acquired":true,"shares":1600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":4284,"source":{"system":"sec-edgar","filing":"0000899243-18-001363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318001363/doc4.xml","form_type":"4"}},{"id":4101204,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-11T21:48:51.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option vested and became exercisable on November 17, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter."}],"balance_after":65000,"derivative":{"exercise_price":1.61,"expiration_date":"2025-01-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-000952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318000952/doc4.xml","form_type":"4"}},{"id":4101203,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-11T21:48:51.000Z","date":"2018-01-10","kind":"sale","acquired":false,"shares":15000,"price":50,"value":750000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2684,"source":{"system":"sec-edgar","filing":"0000899243-18-000952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318000952/doc4.xml","form_type":"4"}},{"id":4101202,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-01-11T21:48:51.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":15000,"price":1.61,"value":24150.0,"ownership":{"direct":true},"balance_after":17684,"source":{"system":"sec-edgar","filing":"0000899243-18-000952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924318000952/doc4.xml","form_type":"4"}},{"id":4177281,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP, Operations"}}],"security":"Common Stock","published_at":"2017-10-31T20:15:01.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":12500,"price":35,"value":437500.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-025039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317025039/doc4.xml","form_type":"4"}},{"id":4217425,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-09-05T18:37:18.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":2410,"price":30,"value":72300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2684,"source":{"system":"sec-edgar","filing":"0000899243-17-021480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317021480/doc4.xml","form_type":"4"}},{"id":4234958,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-08-14T21:47:53.000Z","date":"2017-08-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-17-020283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317020283/doc4.xml","form_type":"4"}},{"id":4243268,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-08-03T16:36:23.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 17, 2017, the Reporting Person was granted 24,000 RSUs, which vest in equal semi-annual installments over 4 years from February 1, 2017, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 17, 2017, the Reporting Person was granted 24,000 RSUs, which vest in equal semi-annual installments over 4 years from February 1, 2017, subject to the Reporting Person's continued employment with the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":21000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-17-019708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317019708/doc4.xml","form_type":"4"}},{"id":4243267,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-03T16:36:23.000Z","date":"2017-08-01","kind":"tax_withholding","acquired":false,"shares":1128,"price":25.1,"value":28312.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 3,000 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":5094,"source":{"system":"sec-edgar","filing":"0000899243-17-019708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317019708/doc4.xml","form_type":"4"}},{"id":4243266,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-08-03T16:36:23.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":6222,"source":{"system":"sec-edgar","filing":"0000899243-17-019708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317019708/doc4.xml","form_type":"4"}},{"id":4447904,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-02-14T18:59:05.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":812,"price":13.73,"value":11148.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3222,"source":{"system":"sec-edgar","filing":"0000899243-17-004064","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317004064/doc5.xml","form_type":"5"}},{"id":4447903,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2017-02-14T18:59:05.000Z","date":"2016-07-31","kind":"grant","acquired":true,"shares":1185,"price":15.2,"value":18012.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2410,"source":{"system":"sec-edgar","filing":"0000899243-17-004064","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317004064/doc5.xml","form_type":"5"}},{"id":4486134,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-19T18:59:30.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest in equal quarterly installments over 16 quarters from January 17, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":36000,"derivative":{"exercise_price":16.4,"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000899243-17-001587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317001587/doc4.xml","form_type":"4"}},{"id":4486133,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2017-01-19T18:59:30.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2017, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date.  The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer."}],"balance_after":24000,"derivative":{"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000899243-17-001587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924317001587/doc4.xml","form_type":"4"}},{"id":4589763,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-10-03T18:41:10.000Z","date":"2016-09-29","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On April 9, 2015, the reporting person was granted an option to purchase 30,000 shares of Common Stock under the issuer's 2012  Stock Option and Grant Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities.  On September 29, 2016, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 7,500 of the shares underlying such option."}],"balance_after":7500,"derivative":{"exercise_price":3.4,"exercise_date":"2016-09-29","expiration_date":"2025-04-08","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-16-030598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924316030598/doc4.xml","form_type":"4"}},{"id":4605565,"issuer":{"id":123220,"kind":"organization","name":"Global Blood Therapeutics, Inc.","symbol":"GBT"},"owners":[{"id":40502,"kind":"person","name":"Radovich Peter","position":1,"cik":"0001650131","reported_name":"Radovich Peter","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Operations"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-09-12T19:21:41.000Z","date":"2016-09-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 16 equal quarterly installments, with the first installment on December 8, 2016, subject to the recipient's continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":19.89,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-16-028831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629137/000089924316028831/doc4.xml","form_type":"4"}}]}